Search hospitals
>
California
>
Los Angeles
Cedars-Sinai Medical Center
Claim this profile
Los Angeles, California 90048
Global Leader in Breast Cancer
Global Leader in Cancer
Conducts research for Pancreatic Cancer
Conducts research for Lung Cancer
Conducts research for Solid Tumors
1450 reported clinical trials
171 medical researchers
Summary
Cedars-Sinai Medical Center is a medical facility located in Los Angeles, California. This center is recognized for care of Breast Cancer, Cancer, Pancreatic Cancer, Lung Cancer, Solid Tumors and other specialties. Cedars-Sinai Medical Center is involved with conducting 1,450 clinical trials across 1,611 conditions. There are 171 research doctors associated with this hospital, such as Leo Mascarenhas, MD, Fataneh (Fae) Majlessipour, Saibal Kar, MD, and Raj Makkar.
Area of expertise
Breast Cancer
Cedars-Sinai Medical Center has run 105 trials for Breast Cancer. Some of their research focus areas include:
Cancer
Cedars-Sinai Medical Center has run 97 trials for Cancer. Some of their research focus areas include:
Top PIs
Leo Mascarenhas, MD
Children's Hospital Los Angeles
5 years of reported clinical research
Fataneh (Fae) Majlessipour
Cedars Sinai Medical Center
8 years of reported clinical research
Saibal Kar, MD
Los Robles Regional Medical Center
7 years of reported clinical research
Raj Makkar
Cedars-Sinai Medical Center
7 years of reported clinical research
Clinical Trials running at Cedars-Sinai Medical Center
Breast Cancer
Lung Cancer
Skin Cancer
Breast cancer
Crohn's Disease
Kidney Cancer
Non-Hodgkin's Lymphoma
Ovarian Cancer
Cancer
Testicular cancer
RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant
for Breast Cancer
This is a global, multicenter, open-label, randomized Phase 3 study comparing the efficacy and safety of RLY-2608 + fulvestrant to capivasertib + fulvestrant for the treatment of patients with HR+/HER2- ABC with PIK3CA mutation following recurrence or progression on or after treatment with a CDK4/6 inhibitor.
Recruiting
2 awards
Phase 3
5 criteria
Low Dose Tamoxifen
for Breast Cancer
This phase III trial compares the effect of low dose tamoxifen to usual hormonal therapy, including aromatase inhibitors, in treating post-menopausal women with hormone positive, HER2 negative early stage breast cancer. Tamoxifen is in a class of medications known as antiestrogens. It blocks the activity of estrogen (a female hormone) in the breast. This may stop the growth of some breast tumors that need estrogen to grow. Aromatase inhibitors, such as anastrozole, letrozole, and exemestane, prevent the formation of estradiol, a female hormone, by interfering with an aromatase enzyme. Aromatase inhibitors are used as a type of hormone therapy to treat postmenopausal women with hormone-dependent breast cancer. Giving low dose tamoxifen may be more effective compared to usual hormone therapy in treating post-menopausal women with hormone-positive, HER2 negative early stage breast cancer.
Recruiting
2 awards
Phase 3
8 criteria
Shorter Chemo-Immunotherapy Without Anthracyclines
for Breast Cancer
This phase III trial compares the effects of shorter chemotherapy (chemo)-immunotherapy without anthracyclines to usual chemo-immunotherapy for the treatment of early-stage triple negative breast cancer. Paclitaxel is in a class of medications called anti-microtubule agents. It stops cancer cells from growing and dividing and may kill them. Carboplatin is in a class of medications known as platinum-containing compounds. It works in a way similar to the anticancer drug cisplatin, but may be better tolerated than cisplatin. Carboplatin works by killing, stopping or slowing the growth of cancer cells. Cyclophosphamide is in a class of medications called alkylating agents. It works by damaging the cell's deoxyribonucleic acid (DNA) and may kill cancer cells. It may also lower the body's immune response. Docetaxel is in a class of medications called taxanes. It stops cancer cells from growing and dividing and may kill them. Doxorubicin is an anthracycline chemotherapy drug that damages DNA and may kill cancer cells. Pembrolizumab may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Shorter treatment without anthracycline chemotherapy may work the same as the usual anthracycline chemotherapy treatment for early-stage triple negative breast cancer.
Recruiting
2 awards
Phase 3
47 criteria
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at Cedars-Sinai Medical Center?
Cedars-Sinai Medical Center is a medical facility located in Los Angeles, California. This center is recognized for care of Breast Cancer, Cancer, Pancreatic Cancer, Lung Cancer, Solid Tumors and other specialties. Cedars-Sinai Medical Center is involved with conducting 1,450 clinical trials across 1,611 conditions. There are 171 research doctors associated with this hospital, such as Leo Mascarenhas, MD, Fataneh (Fae) Majlessipour, Saibal Kar, MD, and Raj Makkar.
Where is Cedars-Sinai Medical Center located?
**Cedars-Sinai Medical Center** - **Address:** 8700 Beverly Blvd, Los Angeles, CA 90048 - **Directions:** Take the I-10 E or I-10 W to exit 7B for La Cienega Blvd. Head north on La Cienega Blvd and turn right onto Beverly Blvd.
Who should I call to ask about financial aid or insurance network?
**Cedars-Sinai Medical Center Contact Information:** - **Patient Financial Services:** - General Inquiries: (323) 866-8600 - Billing and Insurance Inquiries: 866-803-1777 (Monday through Friday, 8 am - 4:30 pm PT) - **Patient Financial Advocates:** - For Admitted Patients: 310-423-5071 For financial assistance, please visit our website at [cedars-sinai.org/billing-insurance/help-paying-your-bill.html](cedars-sinai.org/billing-insurance/help-paying-your-bill.html) to access the necessary resources.
What insurance does Cedars-Sinai Medical Center accept?
Cedars-Sinai Medical Center accepts more than 100 insurance plans, including private insurance, HMOs, and PPOs. They have contracts with Blue Cross PPO, Vivity HMO, and Blue Cross HMO, which may necessitate PCP selection and referrals for specific services. Additionally, they provide resources for individuals looking to purchase health insurance independently, with Blue Shield PPO covering their medical center and physicians.
What awards or recognition has Cedars-Sinai Medical Center received?
Cedars-Sinai Medical Center, located in Los Angeles, California, is celebrated for its exceptional medical care, having won the NRC Health's Consumer Choice Award for 20 consecutive years. It stands as a premier center for biomedical research, ranking among the top non-university hospitals in the US for competitive research funding from the National Institutes of Health.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.